3-1 | Democratic Republic of the Congo -- A million children immunized,Chechnya -- overcoming operational challenges,Malawi -- 10 years of antiretrovirals,Lebanon -- Healing invisible wounds
2-18 | In July 2002, Fred MINANDI, one of MSF's first patients in Malawi to receive antiretroviral drugs (ARVs), spoke about his daily life at the 14th international conference on HIV/AIDS, held in Barcelona. At that time, donors refused to fund HIV/AIDS programs as they did not believe that African patients would take ARVs on a daily basis. Fred Minandi is still receiving treatment today and is doing well."Hello. My name is Fred Minandi. I am 42 years old and I am a farmer from Malawi. I am lucky to be one of MSF's patients benefiting from ARVs.
2-18 | Martha HUCKABEE was head of mission in Malawi from June 2009 to December 2010. While patient treatment in Malawi has changed significantly over 10 years, the new World Health Organization (WHO) directives create new challenges – particularly financial ones.How will the new WHO recommendations benefit HIV/AIDS patients?
1-28 | Licenses just agreed between three generic manufacturers and pharmaceutical company Tibotec, owned by Johnson & Johnson, will keep a promising new AIDS medicine out of the hands of many patients across the developing world, the international medical humanitarian organisation Médecins Sans Frontières (MSF) said today. The licenses exclude many developing countries where Johnson & Johnson/ Tibotec will likely charge high prices. Other precise restrictions introduced by the agreement must be scrutinised carefully.
1-4 | In 2010, southern Sudan battled to contain its biggest kala azar outbreak in eight years, highlighting the urgent need for newer better tools to treat neglected tropical diseases in developing countries.